. The recombinant protein Rv3339c purified using media containing 500 mM glycylglycine is biochemically active. Mycobacterium tuberculosis isocitrate dehydrogenase-1 activity was measured spectrophotometrically by monitoring the time-dependent reduction of NADP + to NADPH at 25°C at 340 nm. The standard assay solution per 400 μL contained 20 mM triethanolamine chloride buffer, pH 7.5, 2 mM NADP + , 0.03 mM DL-isocitrate, 10 mM MgCl 2 , 100 mM NaCl, and 100 pmol of the enzyme.
INTRODUCTION
Escherichia coli is the most widely used system for the rapid and economical production of recombinant proteins because of its very well-characterized genetics and rapid growth rate in inexpensive culture media. One major disadvantage of E. coli is that heterologous proteins are often expressed as insoluble aggregates of folding intermediates known as inclusion bodies. Expression in soluble fraction is paramount for the expressed protein to be biologically active. In order to recover soluble proteins from the inclusion bodies, the inclusion bodies are solubilized in the presence of strong denaturants such as urea or guanidinium hydrochloride, followed by the removal of the denaturants under optimal conditions that favor refolding. Although considerable progress has been made for efficient refolding of proteins (1) , specific folding conditions differ greatly from protein to protein. Even under optimal conditions of refolding, quite a large number of proteins are found to be recalcitrant to refolding, and the yield of renatured protein is relatively low.
Several general and protein-specific methods are available for increased solubility of expressed proteins in E. coli. One approach is the coexpression of molecular chaperones, which assists in the correct folding of the heterologous protein (2, 3) . Similarly, concomitant overexpression of thioredoxin (TrxA) is known to improve the solubility of the expressed proteins (4) . Another approach that has gained considerable success in recent years is the use of gene fusion (5) . Fusion partners such as glutathione-S-transferase (GST) and maltose binding protein (MBP) are known to impart solubility of many heterologous proteins in addition to serving as a tag for affinity purification. Sometimes, soluble expression can also be enhanced by supplying essential cofactors necessary for the activity of the protein in question. For example, soluble expression of human cystathionine β-synthase, a heme-containing protein, could be increased over 8-fold by the addition of the heme precursor δ-aminolevulinic acid (δ-ALA) to the culture medium (6) . In some instances, coexpression of nuclear receptor partners is also found to increase the solubility of nuclear receptors expressed in E. coli (7) . In yet other cases, specific substitution of some amino acid residues was found to enhance the solubility of the expressed proteins (8) . In this report, we describe a novel method of enhancing the solubility of expressed proteins by inducing recombinant protein expression in the presence of the dipeptide glycylglycine.
We deliberately chose as an example mycobacterial proteins that are known to be difficult to express as soluble proteins in E. coli. The solubilization of these proteins was enhanced up to 170-fold.
MATERIALS AND METHODS

Preparation of Recombinant Constructs
The open reading frames (ORFs) Rv0256c, Rv2430c (both are the members of the PPE gene family), Rv3339c (isocitrate dehydrogenase-1), and Rv1609 (anthranilate synthase) of Mycobacterium tuberculosis were amplified from the genomic DNA of the strain H37Rv by PCR. Oligodeoxyribonucleotide primers were chemically synthesized (Microsynth GmbH, Balgach, Switzerland), with appropriate restriction sites suitable for in-frame cloning into expression vectors, with N-terminal 6x-histidine tags. The primers used for amplification are shown in Table 1 . The recombinant proteins were expressed as N-terminal Histagged fusions. The positive clones were confirmed by DNA sequencing.
Cell Culture
Competent BL21(DE3)pLysS cells (Novagen, Abingdon, UK) were transformed with pRSET256, pRSET1609, and pRSET3339 plasmid DNA, and the colonies were grown overnight on Luria Bertani (LB) plates (9) containing 100 μg/mL ampicillin. For pQE2430, competent M15(pREP4) cells (Qiagen GmbH, Hilden, Germany) were used and grown in LB plates containing ampicillin (100 μg/mL) and kanamycin (50 μg/mL). Fresh colonies were first inoculated into 5 mL LB media containing appropriate antibiotics and grown overnight at 37°C with shaking. These overnight cultures were diluted 10-fold into 10 mL Terrific Broth (TB) medium (9), containing different concentrations (0, 50, 200, 500, and 1000 mM) of glycylglycine (Amersham Biosciences, Buckinghamshire, UK) and further grown at 37°C in an orbitory shaker till the absorbance (A) 600 = 1. The cultures were cooled to room temperature, and protein expression was induced with 0.5 mM isopropyl-β-d-thiogalactoside (IPTG) for 14-16 h at 27°C. 
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Preparation of Cell Lysate and Protein Solubility Analysis
The induced cells were centrifuged at 10,000× g, and the cell pellet was resuspended in extraction buffer (50 mM sodium phosphate, pH 8.0, 300 mM NaCl) with lysozyme to a final concentration of 1 mg/mL and incubated on ice for 30 min, followed by sonication 5 times with a burst duration of 15 s each. The sonicated lysates were centrifuged at 18,000× g for 10 min, and the supernatants containing the soluble proteins were collected into fresh tubes. The concentration of total protein in supernatant was estimated using a Bio-Rad DC™ Protein Assay Kit (Bio-Rad Laboratories, Hertfordshire, UK). About 60 μg of protein from each supernatant were electrophoresed in a 12% sodium dodecyl sulfate (SDS) polyacrylamide gel (10) and transblotted onto a nitrocellulose membrane (Hybond™-ECL™; Amersham Biosciences) at 300 mA for 2 h at 4°C in a transfer buffer (25 mM Tris-HCl, 190 mM glycine, 20% methanol). The membrane was blocked for 1 h in phosphate-buffered saline (PBS; Reference 9) containing 4% non-fat dry milk and then incubated with 1:200 diluted monoclonal anti-his tag antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) in PBS. The membrane was washed thrice with excess PBST (PBS containing 0.1% Tween ® 20) for 15 min each. Goat antimouse immunoglobulin G (IgG)-horseradish peroxidase (HRP) conjugate (Amersham Biosciences) was used at 1:10,000 dilution as the second antibody. The membrane was again washed thrice for 5 min each with PBST. The reactive bands were developed by chemiluminescence with luminol reagents (Santa Cruz Biotechnology). All the experiments were performed at least three times, and the representative blots are presented (Figures 1-3) .
Densitometric Analyses
Densitometric analyses were performed using National Institutes of Health (NIH)-Image software, available in the public domain (http://rsb. info.nih.gov/nihi m a g e / D e f a u l t . html), developed by Wayne Rasband for Macintosh ® computers.
Biochemical Activity Assays
The isocitrate dehydrogenase-1 activity of the purified Rv3339c solubilized in the presence of 500 mM glycylglycine in the medium was measured spectrophotometrically by monitoring the time-dependent reduction of NADP + to NADPH at 25°C at 340 nm.
The standard assay solution contained 20 mM triethanolamine chloride buffer, pH 7.5, 2 mM NADP + , 0.03 mM DL-isocitrate, 10 mM MgCl 2 , 100 mM NaCl, and 100 pmol of the enzyme in a total reaction volume of 400 μL.
RESULTS AND DISCUSSION
All the ORFs, Rv0256c, and Rv2430c belonging to the PPE family of proteins and Rv1609 (anthranilate synthase) and Rv3339c (isocitrate dehydogenase-1) of M. tuberculosis were found to have enhanced solubility in the presence of the dipeptide glycylglycine in TB media. Because these proteins were expressed with an N-terminal histidine tag, the relative amount of protein going into the soluble fractions was determined by subjecting equal amounts of soluble proteins to SDS polyacrylamide gel electrophoresis (PAGE) and subsequent detection by Western blot analysis using monoclonal anti-his tag antibodies. In the case of Rv0256c, the amount of soluble protein 
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was very low when grown in the absence of glycylglycine ( Figure 1A ). However, with the increasing concentrations of glycylglycine, the amount of soluble protein dramatically increased, with 1 M glycylglycine being the most effective. In the presence of 1 M glycylglycine, there was a more than 170-fold increase in solubility. Use of glycylglycine higher than 1 M was found to affect the growth of the bacteria (data not shown); therefore, concentrations greater than 1 M were not used. For the other proteins, Rv2430c, Rv1609 (anthranilate synthase), Rv3339c (isocitrate dehydrogenase-1), our initial attempts to express these proteins in soluble form employing various other strategies such as low temperature induction, induction at low IPTG concentration, etc., proved to be futile.
However, when we induced these proteins in the presence of glycylglycine, soluble proteins were readily detected as compared to the undetectable level in experiments without glycylglycine ( Figure  2 , A-C). For Rv3339c, the maximum soluble yield was in the presence of 500 mM glycylglycine (Figure 2A) , whereas for Rv1609, the maximum soluble expression was achieved in presence of 1 M glycylglycine ( Figure 2B ). Similarly, in the case of Rv2430c, the soluble expression was maximum in the presence of 200 mM glycylglycine ( Figure 2C) . The results are summarized in Table 2 .
We next tested whether or not the recombinant proteins solubilized in the presence of glycylyglycine possessed biological activity. For this, we purified the soluble protein coded by the Rv3339c ORF, encoding isocitrate dehydrogenase-1, solubilized in the presence of 500 mM glycylglycine in the medium, and assayed its ability to reduce NADP + to NADPH. The purified solubilized protein was found to possess enzymatic activity following a typical Michaelis-Menten reaction kinetics (Figure 3 ) and was stable for over 1 week at 4°C.
We provide a simple and novel way of enhancing solubility of difficult proteins that are otherwise expressed in a nonproductive fashion into inclusion bodies. Inclusion body formation may be a consequence of the rate of protein translation exceeding the capacity of the cell to fold the newly synthesized protein correctly (11) . This phenomenon has been defined as secretory load for the baculovirus insect cell system (12) and has been addressed by reducing the transcription level using a weaker promoter or by allowing more time for the insect cells to process the recombinant protein (13) . Therefore, decreasing the rate of protein production is one of the major strategies to overcome this problem. Some general approaches to achieve this have been to induce the cells at lower temperature (14) , use low IPTG concentration (15) , use weak promoters (16), etc. Yet other methods utilize various "compatible solutes" to induce osmotic stress (17, 18) . Improved solubility has also been reported by the use of a specific host strain in which heterologous proteins can be expressed upon osmotic induction with high salt (19) . Although the method was initially developed to enhance the soluble expression of some of the mycobacterial proteins, this method is also applicable to other proteins refractory to soluble expression in E. coli systems.
The mechanism of glycylglycine-mediated enhanced solubilization remains to be understood. One of the possibilities could be the increased osmolarity of the medium by the dipeptide. Osmotic stress induces the expression of heat shock proteins with chaperone-like activity to assist correct folding. Another possibility is the direct interaction of glycylglycine with the expressed protein by acting as a chemical chaperone (20, 21) . E. coli is known to possess specific transporters for dipetides and oligopeptides. These in turn are of particular advantage to the bacteria, which thrive in the peptide-rich gut lumen environment (22) . Glycylglycine transport behaves similar to other shocksensitive transport systems requiring ATP for its transport (23) . In the presence of higher concentrations of glycylglycine in the media, the bacteria probably ends up spending considerable energy in active glycylglycine transport, thus slowing down the overall metabolic rate including the rate of translation. This probably allows more time for the expressed proteins to be folded correctly. However, it will be interesting to study how a dipeptide can actually help proteins to be folded in its native condition. 
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